HER2 TARGETING AGENT

The present invention provides: an antibody or an antigen-binding fragment thereof which binds to HER2, which is expressed in cancer cells, or a fragment of HER2; a HER2 targeting agent containing either of these; and a pharmaceutical composition containing the HER2 targeting agent. La présente inve...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KANEKO Mika, NAKAYAMA Daisuke, KUROGI Masayuki, KATO Yukinari
Format:	Patent
Sprache:	eng ; fre ; jpn
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention provides: an antibody or an antigen-binding fragment thereof which binds to HER2, which is expressed in cancer cells, or a fragment of HER2; a HER2 targeting agent containing either of these; and a pharmaceutical composition containing the HER2 targeting agent. La présente invention concerne : un anticorps ou un fragment de liaison à l'antigène associé qui se lie au HER2, qui est exprimé dans des cellules cancéreuses, ou un fragment du HER2 ; un agent de ciblage du HER2 contenant l'un ou l'autre de ceux-ci ; et une composition pharmaceutique contenant l'agent de ciblage du HER2. 本発明は、がん細胞に発現するＨＥＲ２またはその断片に結合する抗体またはその抗原結合性断片、これらのいずれかを含むＨＥＲ２標的化剤、当該ＨＥＲ２標的化剤を含む医薬組成物を提供する。